Irreversible electroporation of the pancreas in swine: a pilot study

被引:96
作者
Charpentier, Kevin P. [1 ]
Wolf, Farrah [2 ]
Noble, Lelia [3 ]
Winn, Brody [3 ]
Resnick, Murray [3 ]
Dupuy, Damian E. [2 ]
机构
[1] Brown Univ, Rhode Isl Hosp, Dept Surg, Providence, RI 02903 USA
[2] Brown Univ, Rhode Isl Hosp, Dept Radiol, Providence, RI 02903 USA
[3] Brown Univ, Rhode Isl Hosp, Dept Pathol, Providence, RI 02903 USA
关键词
pancreas; ablation; irreversible; electroporation; NECK-CANCER; THERAPY; HEAD; ABLATION;
D O I
10.1111/j.1477-2574.2010.00174.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Irreversible electroporation (IRE) is a novel, non-thermal method of tissue ablation using short pulses of high-voltage DC current to ablate tissue. Methods: Irreversible electroporation of the pancreas was performed in four domestic female swine using two monopolar probes spaced 9-15 mm apart. Ninety pulses of 1500 V/cm were delivered for each ablation. Results: All animals survived for their designated times of 2 h (n = 1), 2 days (n = 1) and 14 days (n = 2), respectively. No procedure-related complications occurred. Three animals in which probes had been spaced at intervals of 10 +/- 1 mm showed evidence of irreversible ablation, with ablation height ranging from <10 mm to 21 mm and ablation width ranging from <10 mm to 16 mm by gross appearance and triphenyltetrazolium chloride (TTC) staining. The only animal in which probes had been spaced at intervals of 15 mm did not show evidence of irreversible ablation at 2 weeks. This may be secondary to the wider probe spacing and relatively low voltage, which results in a mostly reversible form of electroporation without cell death. Conclusions: Irreversible electroporation appears to be a safe method for pancreas tissue ablation. Staining with TTC can predict the zone of IRE ablation within 2 h of treatment.
引用
收藏
页码:348 / 351
页数:4
相关论文
共 10 条
[1]   Electroporation therapy for head and neck cancer including carotid artery involvement [J].
Allegretti, JP ;
Panje, WR .
LARYNGOSCOPE, 2001, 111 (01) :52-56
[2]  
ALSAKERE B, 2007, PLOS ONE, V11, P1
[3]   The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck [J].
Bloom, DC ;
Goldfarb, PM .
EJSO, 2005, 31 (09) :1029-1035
[4]  
CHARPENTIER KP, 2010, ANN M SOC SURG ONC S
[5]   Imaging guided percutaneous irreversible electroporation: Ultrasound and immunohistological correlation [J].
Lee, Edward W. ;
Loh, Christopher T. ;
Kee, Stephen T. .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2007, 6 (04) :287-293
[6]   Cancer cells ablation with irreversible electroporation [J].
Miller, L ;
Leor, J ;
Rubinsky, B .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2005, 4 (06) :699-705
[7]   Mechanisms of electrochemotherapy [J].
Mir, LM ;
Orlowski, S .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 35 (01) :107-118
[8]   Electroporation therapy of head and neck cancer [J].
Panje, WR ;
Hier, MP ;
Garman, GR ;
Harrell, E ;
Goldman, A ;
Bloch, I .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1998, 107 (09) :779-785
[9]   Enhancing the Effectiveness of Drug-based Cancer Therapy by Electroporation (Electropermeabilization) [J].
Rabussay, Dietmar P. ;
Nanda, Gurvinder S. ;
Goldfarb, Paul M. .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2002, 1 (01) :71-82
[10]   Irreversible electroporation: A new ablation modality - Clinical implications [J].
Rubinsky, Boris ;
Onik, Gary ;
Mikus, Paul .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2007, 6 (01) :37-48